Blueprint Medicines Corporation (BPMC) Dropped -5.74% or -4.49 To Price $73.61 On Wednesday


Blueprint Medicines Corporation (BPMC) dropped -5.74% or -4.49 to $73.61. It is approximately 368547 shares traded, which is 65.37% compare to the average total volume 563826. The market cap of BPMC is $3.59 billion. The year to date change is 46.86%. The 52 week price range is from $44.58 to $89.81. Price of BPMC have changed -4.86% during last week. It have changed -5.49% over last month, 15.14% over last 3 months, 8.37% over last 6 months and -9.67% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BPMC is 79.71. It is 8.29% above current price. The 200-day Moving Averages for BPMC is 68.89. It is -6.41% below current price. The 52-week High is 89.81. It is 22.01% from the current price. The 52-week Low is 44.58. It is -39.44% from current price.

There are some statistics of BPMC. It is has market cap $3.59 billion. The share outstanding is 48.76 million. The average volume is 563826. The percent of top 15 Institution holding is 158.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BPMC is -45.38%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BPMC is -37.69%.


Tags:

Share this post